Biodesix to participate in the 2024 rbccm global healthcare conference

Louisville, colo.--(business wire)---- $bdsx #patientsfirst--biodesix, inc. (nasdaq: bdsx), a leading diagnostic solutions company with a focus in lung disease, announced today that scott hutton, chief executive officer of biodesix, will present and host in-person 1x1 investor meetings at the 2024 rbccm global healthcare conference, which will be held from may 14-15, 2024. 2024 rbccm global healthcare conference fireside chat date: tuesday, may 14, 2024 fireside chat time: 1:35 pm et location: intercontinental new york.
BDSX Ratings Summary
BDSX Quant Ranking